Skip to content

Study of tranexamic acid on hemorrhage in spinal surgery: a randomized controlled trial.

Study of tranexamic acid and controlled hypotension on hemorrhage in spinal surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033597
Enrollment
Unknown
Registered
2020-06-06
Start date
2020-06-10
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal diseases

Interventions

control group:Normal saline

Sponsors

People's Hospital of Xinjiang Uyghur Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
41 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1.Aged > 40 years, no limit on the gender, ASA class I or II; 2.Willing to cooperate with the investigation and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with allergy history of allergy to opioids or TXA; 2. Oral anticoagulant or antiplatelet drugs; 3. Patients with coagulation dysfunction; 4. Patients with subarachnoid hemorrhage; 5. Patients with preoperative venous thrombosis; 6. Patients with complications of important organs; 7. Patients with color blindness or acquired visual impairment.

Design outcomes

Primary

MeasureTime frame
Blood routine index;blood coagulation index;liver and kidney index;intraoperative blood loss;the scores of surgical field quality;occurrence of adverse events;

Countries

china

Contacts

Public ContactLei Yan

People's Hospital of Xinjiang Uyghur Autonomous Region

nmyanlei@yeah.net+86 15099185169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026